Bleichmar Fonti Wants To Retake Lead In Endo Investor Suit
By Matthew Santoni ( February 19, 2021, 3:56 PM EST) -- A Chicago-based retirement fund and attorneys from Bleichmar Fonti & Auld asked a federal judge to reinstate them as leads in a stockholder class action against Endo Pharmaceuticals, arguing that the court erred in ruling that buying Endo stock 97 seconds after news broke of an alleged price-fixing scheme had raised issues disqualifying them....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.